Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 28, 2014 - Issue 16
361
Views
38
CrossRef citations to date
0
Altmetric
Short Communication

Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli

&
Pages 1280-1283 | Received 18 Dec 2013, Accepted 14 Feb 2014, Published online: 13 Mar 2014
 

Abstract

This study was carried out to evaluate the possible efflux-pump inhibitory activity of a gallotannin 1,2,6-tri-O-galloyl-β-d-glucopyranose isolated from Terminalia chebula fruit against multidrug-resistant (MDR) uropathogenic Escherichia coli. Susceptibility tests of antibiotics and ethidium bromide in the presence and absence of isolated gallotannin and phenylalanine-arginine β-naphthylamide (PAβN) were conducted by using the microbroth dilution assay. Ethidium bromide accumulation and efflux assays were performed spectrofluorometrically to elucidate the possible resistance-modifying activity of isolated gallotanin, if any. Minimum inhibitory concentrations of test antibiotics and ethidium bromide were reduced in the presence of isolated gallotannin and PAβN. The isolated gallotannin also demonstrated efflux-pump inhibitory activity against the studied bacteria as evidenced from ethidium bromide accumulation and efflux assays. The isolated gallotannin, 1,2,6-tri-O-galloyl-β-d-glucopyranose exhibited efflux-pump inhibitory activity which may be one of the possible mechanisms of its antibacterial action against MDR uropathogenic E. coli.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.